367 related articles for article (PubMed ID: 23322901)
1. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.
Connolly RM; Nguyen NK; Sukumar S
Clin Cancer Res; 2013 Apr; 19(7):1651-9. PubMed ID: 23322901
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
3. Diverse actions of retinoid receptors in cancer prevention and treatment.
Mongan NP; Gudas LJ
Differentiation; 2007 Nov; 75(9):853-70. PubMed ID: 17634071
[TBL] [Abstract][Full Text] [Related]
4. Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.
Hunsu VO; Facey COB; Fields JZ; Boman BM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299349
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptors: from molecular mechanisms to cancer therapy.
di Masi A; Leboffe L; De Marinis E; Pagano F; Cicconi L; Rochette-Egly C; Lo-Coco F; Ascenzi P; Nervi C
Mol Aspects Med; 2015 Feb; 41():1-115. PubMed ID: 25543955
[TBL] [Abstract][Full Text] [Related]
6. Retinoid pathway and cancer therapeutics.
Bushue N; Wan YJ
Adv Drug Deliv Rev; 2010 Oct; 62(13):1285-98. PubMed ID: 20654663
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
Miller WH
Cancer; 1998 Oct; 83(8):1471-82. PubMed ID: 9781940
[TBL] [Abstract][Full Text] [Related]
8. Retinoids, retinoic acid receptors, and cancer.
Tang XH; Gudas LJ
Annu Rev Pathol; 2011; 6():345-64. PubMed ID: 21073338
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
Zhuang Y; Faria TN; Chambon P; Gudas LJ
Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
[TBL] [Abstract][Full Text] [Related]
11. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
Freemantle SJ; Spinella MJ; Dmitrovsky E
Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
[TBL] [Abstract][Full Text] [Related]
12. All trans retinoic acid and cancer.
Siddikuzzaman ; Guruvayoorappan C; Berlin Grace VM
Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):241-9. PubMed ID: 20929432
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
López-Boado YS; Klaus M; Dawson MI; López-Otín C
J Biol Chem; 1996 Dec; 271(50):32105-11. PubMed ID: 8943263
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
15. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of retinoids in cancer medicine.
Camacho LH
J Biol Regul Homeost Agents; 2003; 17(1):98-114. PubMed ID: 12757024
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
[TBL] [Abstract][Full Text] [Related]
18. International Union of Pharmacology. LX. Retinoic acid receptors.
Germain P; Chambon P; Eichele G; Evans RM; Lazar MA; Leid M; De Lera AR; Lotan R; Mangelsdorf DJ; Gronemeyer H
Pharmacol Rev; 2006 Dec; 58(4):712-25. PubMed ID: 17132850
[TBL] [Abstract][Full Text] [Related]
19. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
20. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.
Garattini E; Gianni' M; Terao M
Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]